Medicofarma Biotech SA
WSE:MDB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Medicofarma Biotech SA
Accrued Liabilities
Medicofarma Biotech SA
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Medicofarma Biotech SA
WSE:MDB
|
Accrued Liabilities
zł3m
|
CAGR 3-Years
211%
|
CAGR 5-Years
127%
|
CAGR 10-Years
N/A
|
|
|
N
|
Nanogroup SA
WSE:NNG
|
Accrued Liabilities
zł228k
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
R
|
Ryvu Therapeutics SA
WSE:RVU
|
Accrued Liabilities
zł3.7m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
5%
|
|
|
S
|
Selvita SA
WSE:SLV
|
Accrued Liabilities
zł11.4m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Medicofarma Biotech SA
Glance View
Medicofarma Biotech SA is a biotechnology company, which focuses on the innovative medicine, medicinal products, and biotechnology products. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2008-11-27. The company is engaged in works on drugs, medical devices and biotechnological products. It's research and development works are carried out in laboratories in Lublin and Poznan.
See Also
What is Medicofarma Biotech SA's Accrued Liabilities?
Accrued Liabilities
3m
PLN
Based on the financial report for Dec 31, 2024, Medicofarma Biotech SA's Accrued Liabilities amounts to 3m PLN.
What is Medicofarma Biotech SA's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
127%
Over the last year, the Accrued Liabilities growth was 10%. The average annual Accrued Liabilities growth rates for Medicofarma Biotech SA have been 211% over the past three years , 127% over the past five years .
